Device for nasal spray
Description
1. Device for nasal spray
The broken lines in the drawings disclose the unclaimed portions of the device for nasal spray only and form no part of the claimed design.
Claims
The ornamental design for a device for nasal spray, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
| 4830224 | May 16, 1989 | Brison |
| D352658 | November 22, 1994 | Yan |
| D355844 | February 28, 1995 | Bishop |
| D433124 | October 31, 2000 | Sheppard |
| D482119 | November 11, 2003 | Pasternak |
| D482120 | November 11, 2003 | Pasternak |
| D527816 | September 5, 2006 | Nishibayashi |
| D528654 | September 19, 2006 | Nishibayashi |
| D607847 | January 12, 2010 | Elliott |
| D624641 | September 28, 2010 | Boclet |
| D681478 | May 7, 2013 | Riffe |
| 8475507 | July 2, 2013 | Dewey |
| D860435 | September 17, 2019 | Wang |
| D928629 | August 24, 2021 | Yang |
| D969992 | November 15, 2022 | Espinoza |
| D971021 | November 29, 2022 | Kansburg |
| D989280 | June 13, 2023 | Lebel |
| D990660 | June 27, 2023 | Lebel |
| D993389 | July 25, 2023 | Graine |
| D993390 | July 25, 2023 | Graine |
| 20050177095 | August 11, 2005 | Tsutsui |
| 20130102998 | April 25, 2013 | Coghill |
| 20130319404 | December 5, 2013 | Feriani |
| 20140224841 | August 14, 2014 | Auerbach |
| 20150080808 | March 19, 2015 | Esteve |
| 20160166564 | June 16, 2016 | Myers |
| 20160166780 | June 16, 2016 | Allsop |
| 20170156981 | June 8, 2017 | Ito |
| 20200009336 | January 9, 2020 | Feng |
| 20200316326 | October 8, 2020 | Petit |
| 20200316627 | October 8, 2020 | Poullain |
| 20220249787 | August 11, 2022 | Kamishita |
| 20220273893 | September 1, 2022 | Lettman |
| 20220296829 | September 22, 2022 | Anderson, Jr. |
| 20220387721 | December 8, 2022 | Decock |
| 20220401439 | December 22, 2022 | Coric |
| 20230050106 | February 16, 2023 | Ierulli |
- “Aptar Pharma's Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression” [online]. worldpharmatoday.com. Retrieved from the Internet: <https://www.worldpharmatoday.com/press-releases/aptar-pharma-s-bidose-nasal-drug-delivery-device-approved-by-u-s-fda-for-breakthrough-treatment-of-depression/> [Retrieved on Sep. 24, 2022].
Patent History
Patent number: D1001997
Type: Grant
Filed: Jul 12, 2021
Date of Patent: Oct 17, 2023
Inventor: Lila Graine (Beynes)
Primary Examiner: Mojtaba Tehrani
Application Number: 35/512,269
Type: Grant
Filed: Jul 12, 2021
Date of Patent: Oct 17, 2023
Inventor: Lila Graine (Beynes)
Primary Examiner: Mojtaba Tehrani
Application Number: 35/512,269
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
